Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PERSONA

Financiado

Two-Photon Excited Near-Infrared Emissive Multifunctional Gold Nanoclusters for...

Two-Photon Excited Near-Infrared Emissive Multifunctional Gold Nanoclusters for Imaging and Photothermal Treatment for Alzheimer's Disease Neurodegenerative diseases are a global epidemic with significant health, social and economic implications and despite intensive research, there is still no cure for them. Alzheimer’s disease (AD) is the most prevalent neurologica... ver más

30/04/2026

CNRS

212K€

Presupuesto del proyecto: 212K€

Líder del proyecto

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 3 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-07-12

HORIZON-MSCA-2022-PF-01-01: MSCA Postdoctoral Fellowships 2022 ExpectedOutcome:

I+D

Cerrada hace 2 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

3 Participantes

CNRS

211.75K€ | Lider

UNIVERSITE LYON 1 CLAUDE BER...

N.D. | Participante

UGA

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PRE2019-088185 NUEVOS NANOVEHICULOS PARA TERANOSTICA DE ENFERMEDADES CEREBR... 98K€ Cerrado

FLORIN FLuorescent nanO-agents for super-Resolution Imaging and seN... 791K€ Cerrado

RYC-2014-15512 Iron-containing nanomaterials in diseases, diagnosis and tre... 309K€ Cerrado

PRE2021-099240 TEST RAPIDOS BASADOS EN NANOMATERIALES PARA DETERMINACION DE... 101K€ Cerrado

PTQ-14-07318 Micro y nanotecnologías para el diagnóstico in vitro: dispos... 63K€ Cerrado

RYC2021-034536-I Nanomedicine strategies for diagnosis and treatment of vario... 236K€ Cerrado

Duración del proyecto: 33 meses Fecha Inicio: 2023-07-12
Fecha Fin: 2026-04-30

Líder del proyecto

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 212K€

Descripción del proyecto Neurodegenerative diseases are a global epidemic with significant health, social and economic implications and despite intensive research, there is still no cure for them. Alzheimer’s disease (AD) is the most prevalent neurological disorder having symptoms of the progressive memory loss, neuronal cell death, loss of immune response and cognitive function, eventually leading to patient death. Amyloid-β (Aβ) protein is the main neuropathic agent in AD and aggregation of Aβ plaques are found in the brain tissue of patients suffering from this disease. The application of nanomaterials has emerged as a new frontier in nanomedicine for the treatment of AD. Among various nanomaterials, ultrasmall gold nanoclusters (Au NCs) may serve as a promising choice for the diagnosis and treatment of AD from the very early stage which can be well justified by the advantages of Au NCs in terms of their diverse physicochemical properties, biocompatibility and biodistribution, high surface to volume ratio, ease for functionalisation and drug loading, blood–brain barrier (BBB) translocation and the possibility of two-photon excitation. The main objective of our research is to advance in the development of new, biocompatible multifunctional nanomaterials for the detection of amyloids with high spatial resolution and the subsequent degradation of amyloid aggregates using a non-invasive approach. In this regard, the blinking and non-linear optical properties of the Au NCs enable its potential for nanoscopic imaging of amyloid and two-photon photothermal ablation of amyloid aggregates. Another advantage of the proposed multifunctional nanomaterials is that they can also be used as drug delivery vehicles to penetrate the cell membrane and BBB to deliver anti-amyloid drugs that exhibit effective imaging-guided photothermal efficacy. This research will use state-of-the-art technology to develop a multifunctional phototheranostic nanomedicine for the detection and treatment of amyloid diseases.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores